Cargando…
The Trend of IgG and IgM Antibodies During 6-Month Period After the Disease Episode in COVID-19 Patients
SARS-CoV-2 is a newly emerged coronavirus that has been widely transmitted since late 2019. It has caused a pandemic and infected roughly 450 million people globally.Hitherto, there is no approved anti-COVID-19 treatment, and vaccination is the only experienced preventive strategy. It mainly promote...
Autores principales: | Ghasemi, Darioush, Araeynejad, Faridoddin, Maghsoud, Omid, Gerami, Nafiseh, Keihan, Amir Homayoun, Rezaie, Ehsan, Mehdizadeh, Saber, Hosseinzadeh, Ramin, Mohammadi, Ramtin, Bahardoust, Mansour, Heiat, Mohammad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9702912/ https://www.ncbi.nlm.nih.gov/pubmed/36466050 http://dx.doi.org/10.1007/s40995-022-01382-7 |
Ejemplares similares
-
Helper T cells reacting to idiotype on IgG but not IgM
Publicado: (1985) -
Serum IgA, IgM, and IgG responses in COVID-19
por: Ma, Huan, et al.
Publicado: (2020) -
Serologic Tests of IgG and IgM Antibodies and IgG Avidity for Diagnosis of Ocular Toxoplasmosis
por: Rahimi-Esboei, Bahman, et al.
Publicado: (2018) -
Association of dengue infection with anti-alpha-gal antibodies, IgM, IgG, IgG1, and IgG2
por: Olajiga, Olayinka M., et al.
Publicado: (2022) -
Reference ranges for serum immunoglobulin (IgG, IgA, and IgM) and IgG subclass levels in healthy children
por: BAYRAM, Rumeysa Olcay, et al.
Publicado: (2019)